Long-term Survival Benefit of Eculizumab Treatment in Patients With Paroxysmal Nocturnal Haemoglobinuria: Data From the International PNH Registry

被引：0
|
作者：
Griffin, Morag [1 ]
Terriou, Louis [2 ]
Patriquin, Christopher J. [3 ]
Lee, Jong Wook [4 ]
Gustovic, Philippe [5 ]
Patel, Ami S. [6 ]
Szer, Jeff [7 ,8 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, Dept Haematol, Leeds, W Yorkshire, England
[2] CHU Lille, Serv Med Interne & Immunol Clin, Lille, France
[3] Univ Toronto, Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON, Canada
[4] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol, Seoul, South Korea
[5] Alex, AstraZeneca Rare Dis, Zurich, Switzerland
[6] Alex, AstraZeneca Rare Dis, Boston, MA USA
[7] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH22-OR06
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [21] EFFECT OF ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS WITH OR WITHOUT HIGH DISEASE ACTIVITY: RESULTS FROM THE INTERNATIONAL PNH REGISTRY
    Hoechsmann, B.
    de Fontbrune, F. Sicre
    Lee, J. W.
    Kulagin, A.
    Hillmen, P.
    Wilson, A.
    Marantz, J.
    Schrezenmeier, H.
    HAEMATOLOGICA, 2017, 102 : 188 - 189
  • [22] The incidence and prevalence of paroxysmal nocturnal haemoglobinuria (PNH) and survival of patients in Yorkshire
    Hill, A.
    Platts, P. J.
    Smith, A.
    Richards, S. J.
    Cullen, M. J.
    Hill, Q. A.
    Roman, E.
    Hillmen, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 31 - 31
  • [23] Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry
    Socie, G.
    Schrezenmeier, H.
    Muus, P.
    Lisukov, I.
    Roeth, A.
    Kulasekararaj, A.
    Lee, J. W.
    Araten, D.
    Hill, A.
    Brodsky, R.
    Urbano-Ispizua, A.
    Szer, J.
    Wilson, A.
    Hillmen, P.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (09) : 1044 - 1053
  • [24] Outcome characteristics of patients with paroxysmal nocturnal hemoglobinuria (PNH): data from the German PNH registry including eculizumab, ravulizumab and untreated patients
    Roth, A.
    Alashkar, F.
    Panse, J.
    Sockel, K.
    Haferlach, T.
    Hubel, K.
    Blau, I. W.
    Platzbecker, U.
    Hochsmann, B.
    Schrezenmeier, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 174 - 174
  • [25] Survival benefit of eculizumab in patients with paroxysmal nocturnal hemoglobinuria
    Patel, Ami
    Metzger, Jesse
    Terriou, Louis
    Patriquin, Christopher
    Griffin, Morag
    Lee, Jong Wook
    Gustovic, Phillippe
    Jiang, Wei
    Szer, Jeff
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 264 - 265
  • [26] Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
    Kelly, Richard J.
    Hill, Anita
    Arnold, Louise M.
    Brooksbank, Gemma L.
    Richards, Stephen J.
    Cullen, Matthew
    Mitchell, Lindsay D.
    Cohen, Dena R.
    Gregory, Walter M.
    Hillmen, Peter
    BLOOD, 2011, 117 (25) : 6786 - 6792
  • [27] Clinical Benefit of Eculizumab in Patients with No Transfusion History in the International Paroxysmal Nocturnal Hemoglobinuria Registry
    Almeida, Antonio Medina
    Bedrosian, Camille L.
    Cole, Alexander
    Muus, Petra
    Schrezenmeier, Hubert
    Szer, Jeff
    Urbano-Ispizua, Alvaro
    Rosse, Wendell F.
    BLOOD, 2015, 126 (23)
  • [28] Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Szer, Jeffrey
    Muus, Petra
    Roeth, Alexander
    Elebute, M. O.
    Risitano, Antonio M.
    Schrezenmeier, Hubert
    Maciejewski, Jaroslaw P.
    Urbano-Ispizua, Alvaro
    de Castro, Carlos Manuel, III
    Socie, Gerard
    Brodsky, Robert A.
    BLOOD, 2012, 120 (21)
  • [29] Use and effect of eculizumab (ecu) in paroxysmal nocturnal hemoglobinuria (PNH) patients with or without high disease activity: Results from the International PNH Registry
    Hoechsmann, B.
    de Fontbrune, F. S.
    Lee, J-W
    Kulagin, A.
    Hillmen, P.
    Wilson, A.
    Marantz, J.
    Schrezenmeier, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 127 - 127
  • [30] IMPROVED FATIGUE AND QUALITY-OF-LIFE IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DURING TREATMENT WITH ECULIZUMAB: DATA FROM THE GLOBAL PNH REGISTRY
    Muus, Petra
    Schrezenmeier, H.
    Socie, G.
    Maciejewski, J. P.
    Szer, J.
    Brodsky, R. A.
    Urbano-Ispizua, A.
    Bessler, M.
    Kanakura, Y.
    Rosse, W.
    Khursigara, G.
    Bedrosian, C. L.
    Hillmen, P.
    HAEMATOLOGICA, 2013, 98 : 83 - 84
12345